WO2004076637A3 - Cell-polymer fiber compositions and use thereof - Google Patents
Cell-polymer fiber compositions and use thereof Download PDFInfo
- Publication number
- WO2004076637A3 WO2004076637A3 PCT/US2004/005648 US2004005648W WO2004076637A3 WO 2004076637 A3 WO2004076637 A3 WO 2004076637A3 US 2004005648 W US2004005648 W US 2004005648W WO 2004076637 A3 WO2004076637 A3 WO 2004076637A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- cell
- polymer fiber
- fiber compositions
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/0231—Chemically defined matrices, e.g. alginate gels, for immobilising, holding or storing cells, tissue or organs for preservation purposes; Chemically altering or fixing cells, tissue or organs, e.g. by cross-linking, for preservation purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004214932A AU2004214932B2 (en) | 2003-02-24 | 2004-02-24 | Cell-polymer fiber compositions and use thereof |
EP04714215.3A EP1601757B1 (en) | 2003-02-24 | 2004-02-24 | Cell-polymer fiber compositions and use thereof |
NZ542501A NZ542501A (en) | 2003-02-24 | 2004-02-24 | Compositions comprising chitin or chitosan and use thereof |
JP2006503874A JP5028086B2 (en) | 2003-02-24 | 2004-02-24 | Cell-polymer fiber composition and use thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44947803P | 2003-02-24 | 2003-02-24 | |
US60/449,478 | 2003-02-24 | ||
US45019503P | 2003-02-25 | 2003-02-25 | |
US60/450,195 | 2003-02-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004076637A2 WO2004076637A2 (en) | 2004-09-10 |
WO2004076637A3 true WO2004076637A3 (en) | 2005-12-22 |
Family
ID=32930513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/005648 WO2004076637A2 (en) | 2003-02-24 | 2004-02-24 | Cell-polymer fiber compositions and use thereof |
Country Status (6)
Country | Link |
---|---|
US (3) | US7285266B2 (en) |
EP (1) | EP1601757B1 (en) |
JP (1) | JP5028086B2 (en) |
AU (1) | AU2004214932B2 (en) |
NZ (1) | NZ542501A (en) |
WO (1) | WO2004076637A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8858964B2 (en) | 2010-04-15 | 2014-10-14 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly-N-acetylglucosamine nanofibers |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7041657B2 (en) * | 2001-02-12 | 2006-05-09 | Marine Polymer Technologies Inc. | Compositions and methods for modulation of vascular structure and/or function |
WO2004060172A1 (en) | 2002-12-31 | 2004-07-22 | Marine Polymer Technologies, Inc. | Hemostatic compositions and uses therefor |
JP5028086B2 (en) * | 2003-02-24 | 2012-09-19 | マリン ポリマー テクノロジーズ,インコーポレーテッド | Cell-polymer fiber composition and use thereof |
US8152750B2 (en) | 2003-09-12 | 2012-04-10 | Marine Polymer Technologies, Inc. | Vascular access preservation in hemodialysis patients |
US20050180957A1 (en) * | 2004-01-16 | 2005-08-18 | Scharp David W. | Method of using fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells |
WO2005089420A2 (en) * | 2004-03-16 | 2005-09-29 | Theradigm, Inc. | Expansion of neural stem cells with lif |
EP1853278A4 (en) * | 2005-02-18 | 2011-12-28 | Cartilix Inc | Glucosamine materials |
WO2006102470A2 (en) * | 2005-03-22 | 2006-09-28 | Posnick, Jeffrey, C. | Facial implant |
JP4775663B2 (en) * | 2005-03-30 | 2011-09-21 | 地方独立行政法人 大阪府立病院機構 | Angiogenesis control method |
US7573182B2 (en) * | 2005-06-01 | 2009-08-11 | Prorhythm, Inc. | Ultrasonic transducer |
US20080286865A1 (en) * | 2005-10-13 | 2008-11-20 | Connie Lynn Erickson-Miller | Methods for the Preservation of Platelet Efficacy During Storage |
US20060287654A1 (en) * | 2006-08-11 | 2006-12-21 | Jeffrey Posnick | Implant securing device and method |
US20080107632A1 (en) * | 2006-09-06 | 2008-05-08 | Henrich Cheng | Fibrin glue composition for repairing nerve damage and methods thereof |
AU2013202662B2 (en) * | 2007-02-19 | 2015-09-03 | Marine Polymer Technologies, Inc. | Hemostatic compositions and therapeutic regimens |
ES2621018T3 (en) * | 2007-02-19 | 2017-06-30 | Marine Polymer Technologies, Inc. | Hemostatic compositions and therapeutic regimens |
AU2015264846B2 (en) * | 2007-02-19 | 2017-08-10 | Marine Polymer Technologies, Inc. | Hemostatic compositions and therapeutic regimens |
EP2129718A2 (en) * | 2007-03-27 | 2009-12-09 | Buckman Laboratories International, Inc. | Compositions and methods to control the growth of microorganisms in aqueous systems |
EP1997457B1 (en) * | 2007-06-01 | 2010-11-10 | Allergan, Inc. | Biological tissue growth support through induced tensile stress |
EP2173378B1 (en) | 2007-06-27 | 2014-03-19 | Admune Therapeutics LLC | Complexes of il-15 and il-15ralpha and uses thereof |
US8486033B2 (en) * | 2007-07-18 | 2013-07-16 | Marine Polymer Technologies, Inc. | Application of polymeric materials to screens to facilitate hemostasis and wound healing |
EP2192907B1 (en) * | 2007-08-16 | 2018-04-18 | Remedor Biomed Ltd. | Erythropoietin and fibronectin compositions for therapeutic applications |
IT1392897B1 (en) | 2008-07-18 | 2012-04-02 | Fond Ircss Ca' Granda - Ospedale Maggiore Policlinico | PIASTRINIC FRACTION DERIVING FROM PLACENTED BLOOD |
US20100291182A1 (en) * | 2009-01-21 | 2010-11-18 | Arsenal Medical, Inc. | Drug-Loaded Fibers |
US9018159B2 (en) | 2009-03-12 | 2015-04-28 | Landing Biotech, Inc. | Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof |
EP2229952B1 (en) * | 2009-03-12 | 2014-08-13 | Jian-Ning Liu | Plasma anti-diabetic NUCB2 peptide (pladin and nesfatin-1n) and uses thereof |
US20100234274A1 (en) * | 2009-03-12 | 2010-09-16 | Jian-Ning Liu | Use of Nestafin-1 in the Treatment for Diabetes |
US10420862B2 (en) | 2009-08-24 | 2019-09-24 | Aresenal AAA, LLC. | In-situ forming foams for treatment of aneurysms |
US9173817B2 (en) | 2009-08-24 | 2015-11-03 | Arsenal Medical, Inc. | In situ forming hemostatic foam implants |
US9044580B2 (en) | 2009-08-24 | 2015-06-02 | Arsenal Medical, Inc. | In-situ forming foams with outer layer |
US20110202016A1 (en) * | 2009-08-24 | 2011-08-18 | Arsenal Medical, Inc. | Systems and methods relating to polymer foams |
AU2016200853B2 (en) * | 2010-04-15 | 2017-10-26 | Marine Polymer Technologies, Inc | Anti-bacterial applications of poly–n-acetylglucosamine nanofibers |
US9555171B2 (en) | 2010-09-30 | 2017-01-31 | Depuy Mitek, Llc | Methods and devices for collecting separate components of whole blood |
US9034240B2 (en) | 2011-01-31 | 2015-05-19 | Arsenal Medical, Inc. | Electrospinning process for fiber manufacture |
US8968626B2 (en) | 2011-01-31 | 2015-03-03 | Arsenal Medical, Inc. | Electrospinning process for manufacture of multi-layered structures |
US9194058B2 (en) | 2011-01-31 | 2015-11-24 | Arsenal Medical, Inc. | Electrospinning process for manufacture of multi-layered structures |
AU2012242479B2 (en) | 2011-04-15 | 2015-04-16 | Marine Polymer Technologies, Inc. | Treatment of disease with poly-n-acetylglucosamine nanofibers |
AU2013205384B2 (en) * | 2011-04-15 | 2016-03-03 | Marine Polymer Technologies, Inc. | Treatment of disease with poly-n-acetylglucosamine nanofibers |
JP5496427B2 (en) * | 2011-09-15 | 2014-05-21 | 国立大学法人鳥取大学 | Inflammatory bowel disease treatment |
US8993831B2 (en) | 2011-11-01 | 2015-03-31 | Arsenal Medical, Inc. | Foam and delivery system for treatment of postpartum hemorrhage |
US9867939B2 (en) | 2013-03-12 | 2018-01-16 | Allergan, Inc. | Adipose tissue combinations, devices, and uses thereof |
US20140350516A1 (en) | 2013-05-23 | 2014-11-27 | Allergan, Inc. | Mechanical syringe accessory |
US9248384B2 (en) | 2013-10-02 | 2016-02-02 | Allergan, Inc. | Fat processing system |
WO2015077401A1 (en) | 2013-11-20 | 2015-05-28 | Drexel University | Compositions and methods for macrophage conversion |
US20150290248A1 (en) * | 2014-04-10 | 2015-10-15 | Nanofiber Health, Inc. | Fibrous component for health, performance, and aesthetic treatment |
US10029048B2 (en) | 2014-05-13 | 2018-07-24 | Allergan, Inc. | High force injection devices |
BR112017019272A2 (en) | 2015-03-10 | 2018-05-02 | Allergan Pharmaceuticals Holdings Ireland Unlimited Company | multiple needle injector |
AU2017246114B2 (en) | 2016-04-08 | 2022-03-17 | Allergan, Inc. | Aspiration and injection device |
RU2675996C1 (en) * | 2017-10-17 | 2018-12-25 | Борис Михайлович Белик | Method of endoscopic hemostasis in ulcer gastroduodenal hemorrhages |
FR3095658B1 (en) | 2019-05-02 | 2022-09-16 | Laboratoires Danjou | Cosmetic care process based on photoactive extracts of microalgae |
US11654057B2 (en) | 2020-04-09 | 2023-05-23 | Bio 54, Llc | Devices for bleeding reduction and methods of making and using the same |
US11642324B1 (en) | 2022-03-01 | 2023-05-09 | Bio 54, Llc | Topical tranexamic acid compositions and methods of use thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292524A (en) * | 1991-09-06 | 1994-03-08 | California Institute Of Technology | Blood platelet loaded with diagnostic or therapeutic-containing liposome or reconstituted Sendai virus |
US5858350A (en) * | 1993-12-01 | 1999-01-12 | Marine Polymer Technologies | Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6150085A (en) | 1998-09-16 | 2000-11-21 | The United States Of America As Represented By The Secretary Of The Army | Prolonged storage of red blood cells and composition |
CA1264442A (en) * | 1984-06-22 | 1990-01-16 | Richard L. Veech | Electrolyte solutions and in vivo use thereof |
US5041138A (en) | 1986-11-20 | 1991-08-20 | Massachusetts Institute Of Technology | Neomorphogenesis of cartilage in vivo from cell culture |
US4846835A (en) | 1987-06-15 | 1989-07-11 | Grande Daniel A | Technique for healing lesions in cartilage |
US5364785A (en) | 1990-02-09 | 1994-11-15 | Genentech, Inc. | Method of isolating lung cell line |
US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5226914A (en) | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
JP3199405B2 (en) | 1991-08-30 | 2001-08-20 | 生化学工業株式会社 | Hepatocyte spherical agglomerating agent and method for producing spherical agglomerated hepatocytes |
US5281700A (en) | 1992-08-11 | 1994-01-25 | The Regents Of The University Of California | Method of recovering endothelial membrane from tissue and applications thereof |
US5446132A (en) | 1992-10-01 | 1995-08-29 | The General Hospital Corporation | Thrombin-activated platelet protein-2 (TAPP-2) |
KR950703640A (en) | 1992-10-09 | 1995-09-20 | 가일 케이,나우톤. | LIVER RESERVE CELLS |
AU687386B2 (en) | 1993-04-08 | 1998-02-26 | Human Cell Cultures, Inc. | Cell culturing method and medium |
US5462870A (en) | 1993-04-23 | 1995-10-31 | Wayne State University | Human diploid salivary gland epithelial cell lines |
US5624679A (en) | 1993-12-01 | 1997-04-29 | Marine Polymer Technologies, Inc. | Methods and compositions for poly-β-1-4-N-acetylglucosamine biological barriers |
US5846952A (en) | 1993-12-01 | 1998-12-08 | Marine Polymer Technologies, Inc. | Methods and compositions for poly-β-1-4-N-acetylglucosamine drug delivery |
US6743783B1 (en) | 1993-12-01 | 2004-06-01 | Marine Polymer Technologies, Inc. | Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine |
US5622834A (en) | 1993-12-01 | 1997-04-22 | Marine Polymer Technologies, Inc. | Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture |
US6063911A (en) | 1993-12-01 | 2000-05-16 | Marine Polymer Technologies, Inc. | Methods and compositions for treatment of cell proliferative disorders |
US5635493A (en) | 1993-12-01 | 1997-06-03 | Marine Polymer Technologies, Inc. | Methods and compositions for poly-β-1-4-N-acetylglucosamine chemotherapeutics |
US5686115A (en) | 1993-12-01 | 1997-11-11 | Marine Polymer Technologies, Inc. | Poly-β-1→4-N-acetylucosamine copolymer composition with collagen |
US6221669B1 (en) | 1994-10-19 | 2001-04-24 | Lifecell Corporation | Prolonged preservation of blood platelets |
US5614204A (en) * | 1995-01-23 | 1997-03-25 | The Regents Of The University Of California | Angiographic vascular occlusion agents and a method for hemostatic occlusion |
US5510102A (en) | 1995-01-23 | 1996-04-23 | The Regents Of The University Of California | Plasma and polymer containing surgical hemostatic adhesives |
US6413713B1 (en) | 1998-10-30 | 2002-07-02 | Hyperbaric Systems | Method for preserving blood platelets |
US7041657B2 (en) | 2001-02-12 | 2006-05-09 | Marine Polymer Technologies Inc. | Compositions and methods for modulation of vascular structure and/or function |
WO2004060172A1 (en) | 2002-12-31 | 2004-07-22 | Marine Polymer Technologies, Inc. | Hemostatic compositions and uses therefor |
JP5028086B2 (en) | 2003-02-24 | 2012-09-19 | マリン ポリマー テクノロジーズ,インコーポレーテッド | Cell-polymer fiber composition and use thereof |
-
2004
- 2004-02-24 JP JP2006503874A patent/JP5028086B2/en not_active Expired - Fee Related
- 2004-02-24 NZ NZ542501A patent/NZ542501A/en not_active IP Right Cessation
- 2004-02-24 EP EP04714215.3A patent/EP1601757B1/en not_active Expired - Lifetime
- 2004-02-24 WO PCT/US2004/005648 patent/WO2004076637A2/en active Application Filing
- 2004-02-24 AU AU2004214932A patent/AU2004214932B2/en not_active Ceased
- 2004-02-24 US US10/787,035 patent/US7285266B2/en not_active Expired - Lifetime
-
2007
- 2007-09-24 US US11/903,935 patent/US20080026064A1/en not_active Abandoned
-
2012
- 2012-05-18 US US13/475,508 patent/US8802083B2/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292524A (en) * | 1991-09-06 | 1994-03-08 | California Institute Of Technology | Blood platelet loaded with diagnostic or therapeutic-containing liposome or reconstituted Sendai virus |
US5858350A (en) * | 1993-12-01 | 1999-01-12 | Marine Polymer Technologies | Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system |
Non-Patent Citations (1)
Title |
---|
OKAMOTO ET AL: "Effect of Chitin and Chitosan on Platelet", vol. 5, 2002, pages 643 - 649, XP009123079 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8858964B2 (en) | 2010-04-15 | 2014-10-14 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly-N-acetylglucosamine nanofibers |
US9198928B2 (en) | 2010-04-15 | 2015-12-01 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly-N-acetylglucosamine nanofibers |
Also Published As
Publication number | Publication date |
---|---|
EP1601757B1 (en) | 2016-11-30 |
US8802083B2 (en) | 2014-08-12 |
JP5028086B2 (en) | 2012-09-19 |
EP1601757A2 (en) | 2005-12-07 |
AU2004214932B2 (en) | 2009-12-03 |
JP2006518764A (en) | 2006-08-17 |
NZ542501A (en) | 2009-09-25 |
WO2004076637A2 (en) | 2004-09-10 |
US20040220140A1 (en) | 2004-11-04 |
US20080026064A1 (en) | 2008-01-31 |
US7285266B2 (en) | 2007-10-23 |
EP1601757A4 (en) | 2008-06-18 |
US20130028980A1 (en) | 2013-01-31 |
AU2004214932A1 (en) | 2004-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004076637A3 (en) | Cell-polymer fiber compositions and use thereof | |
HK1122803A1 (en) | ||
WO2006126095A3 (en) | Biocompatible polymers and co-polymers comprising amino acids in the side chain | |
TN2009000132A1 (en) | Substituted dihydropyrazolones for treating cardiovascular and haematological diseases | |
WO2006054309A3 (en) | Debriding composition from bromelain | |
WO2005079822A3 (en) | Pharmaceutical composition comprising a fibrin matrix and dermal fibroblasts for the treatment of wounds | |
WO2006048829A3 (en) | Preparation of chitin and derivatives thereof for cosmetic and therapeutic use | |
MY144221A (en) | Biocompatible polymer compositions for dual or multistaged curing. | |
WO2003057072A8 (en) | Hemostatic compositions and methods for controlling bleeding | |
NO20035569D0 (en) | Wound dressing and method of controlling life-threatening bleeding | |
WO2003009810A3 (en) | Silver alginate foam compositions | |
MX2012007922A (en) | Dry powder fibrin sealant. | |
ITRM20030210A1 (en) | PROSTHESIS TO BE USED IN THE PROLASSO SURGICAL THERAPY | |
EP2289535B8 (en) | Compositions and methods for promoting wound healing and tissue regeneration | |
WO2007038686A3 (en) | Amniotic membrane preparations and purified compositions and methods of use | |
AU2002252025A1 (en) | Injection molding of living tissues | |
WO2008089439A3 (en) | Methods and compositions for enhancing lifespan involving sirtuin-modulating compounds and chalcogenides | |
WO2007100555A3 (en) | Compositions containing lactoferrin, and methods of using same to promote growth of skin cells | |
WO2009040420A3 (en) | Use of a monoterpene to increase tissue repair | |
WO2007030666A3 (en) | Medicated skin care preparation for promoting wound healing | |
WO2008130607A3 (en) | Wound healing compositions containing keratin biomaterials | |
EP2540301A3 (en) | Methods and pharmaceutical compositions for healing wounds | |
WO2005012492A8 (en) | Human skin equivalents expressing exogenous polypeptides | |
ATE378358T1 (en) | HEPARIN-LIKE COMPOUNDS, THEIR PREPARATION AND USE FOR PREVENTING ARTERIAL THROMBOSIS ASSOCIATED WITH VASCULAR INJURY AND PROCEDURES | |
ATE410195T1 (en) | HYDROCOLLOID COMPOSITIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006503874 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004214932 Country of ref document: AU |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 542501 Country of ref document: NZ |
|
REEP | Request for entry into the european phase |
Ref document number: 2004714215 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004714215 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2004214932 Country of ref document: AU Date of ref document: 20040224 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004214932 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004714215 Country of ref document: EP |